Werewolf Therapeutics, Ambros Therapeutics agree merger, $150 million placement
Werewolf Therapeutics and Ambros Therapeutics announce a merger agreement and a concurrent oversubscribed $150 million private placement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.